Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 797 M957 M888 M950 M1.08 B1 B 3.92 B Research & development 362 M421 M423 M374 M450 M484 M 1.73 B Operating income 616 M484 M576 M611 M611 M676 M 2.47 B Non-Operating Income, Total 79 M64 M61 M64 M58 M58 M 241 M Interest expense, net of interest capitalized 61 M62 M62 M61 M61 M65 M 249 M Non-Operating Income, excl. Interest Expenses 18 M2 M-1 M3 M-3 M-7 M -8 M Unusual income/expense —————— — Pretax income 634 M477 M573 M633 M618 M665 M 2.49 B Equity in earnings —————— — Taxes 129 M108 M-24 M100 M106 M113 M 295 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 505 M369 M597 M533 M512 M552 M 2.19 B Discontinued operations -2 M-1 M35 M3 M0-2 M 36 M Net income 503 M368 M632 M536 M512 M550 M 2.23 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 503 M368 M632 M528 M512 M550 M 2.22 B Basic earnings per share (Basic EPS) 1.080.81.391.181.141.24 4.95 Diluted earnings per share (Diluted EPS) 1.060.791.351.161.121.21 4.84 Average basic shares outstanding 467 M461 M456 M459 M448 M445 M — Diluted shares outstanding 475 M470 M467 M468 M457 M455 M — EBITDA 628 M497 M588 M——— — EBIT 616 M484 M576 M601 M611 M676 M 2.46 B Cost of revenue 723 M776 M821 M901 M802 M832 M 3.36 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 12 M13 M12 M——— —